patents
ANALYSIS: The challenges of forecasting biosimilar sales across Europe
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts
The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …
OPINION: ‘More work remains if biosimilars are to fulfil their potential’
October 27, 2015Manufacturing and Production, Research and Development, Sales and Marketing British Generic Manufacturers Association, NHS, bgma, biosimilars, generics, patent cliff, patents
Despite having a mature generics market which fulfils more than three-quarters of all prescriptions in the UK, and as a …
Future Focus: The industry’s top five biggest drug patent expirations in 2016
October 21, 2015Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents
From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …
Daiichi sheds more US jobs as generic losses take their toll
October 20, 2015Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies
The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …
UK second in global innovation index
September 18, 2015Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo
The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …
Lundbeck sheds 1,000 jobs in £284 million restructure
August 20, 2015Manufacturing and Production, Sales and Marketing Lundbeck, generics, job losses, patents, redundancies, restructure, restructuring
Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …
Pfizer offers to pay for UK Lyrica switches
August 13, 2015Lyrica, NHS England, Pfizer, generics, neuropathic pain, patents, pregabalin
Pfizer is to pay the administrative costs of GPs to switch patients to Lyrica from generic versions of pregabalin, as …
The Pharmafocus debate: Is the price of new hepatitis C treatments fair?
April 27, 2015Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi
YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …
GSK settles cancer patent dispute
March 28, 2012Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents
GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab. The US patents, which relate to recombinant antibody …
India’s Nexavar patent ruling disturbs pharma
March 12, 2012Sales and Marketing India, emerging markets, intellectual property, patents
India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …
Novartis Indian patent battle nears conclusion
March 7, 2012Sales and Marketing Glivec, HIV, India, Novartis, patents
A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …
Pharma unprepared for annus horribilis
January 12, 2012Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma
A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …
European judge rules against stem cell patents
October 19, 2011Research and Development Stem cells, patents
The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …
European scrutiny of pharma patent deals to continue
July 6, 2010Sales and Marketing European Commission, competition, patents
Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …
India revokes Roche’s Valcyte patent
May 19, 2010Sales and Marketing India, Roche, patents
Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
